A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids

Clinical trial NCT05952856 · COMPLETED

Trial details

NCT number: NCT05952856
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypercholesterolemia Familial Hypercholesterolemia

Start date: 2023-08-10
Primary completion: 2025-07-28
Enrollment: 2912

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.